Company intelligence / Profile preview

Brightonix Imaging

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

Brightonix Imaging develops AI solutions for imaging and compact PET insert devices for simultaneous PET/MRI studies in small animals and clinical brain PET applications. The company has received regulatory approvals including FDA 510(k) clearance for PHAROS and Korea MFDS (K-FDA) approvals for multiple products

Therapeutic areas: Neurology
Modalities: Device
Industry: Medical Imaging

Partnerships

Aspect Imaging (Israel) - MOU on PET/MRI development and exclusive domestic supplier contractUC Davis, USANational Institute of Health (NIH), USAKorea Radioisotope Center for Pharmaceuticals

Beyond the preview

Go deeper on Brightonix Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brightonix Imaging.

Explore the full profile